Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alec Morton

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
BMJ Open|May 7, 2026
Economic evaluations of digital health interventions on maternal, newborn and child health in low-income and middle-income countries: a systematic review protocolFei Wu, Brenda Soun, Binqi Zhan, et al.
BMJ Global Health|September 3, 2021
The economics of improving global infectious disease surveillanceLinda de Vries, Marion Koopmans, Alec Morton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 14, 2014
STAR--people-powered prioritization: a 21st-century solution to allocation headachesMara Airoldi, Alec Morton, Jenifer A E Smith, et al.
Health Care Management Science|June 28, 2008
Requisite models for strategic commissioning: the example of type 1 diabetesMara Airoldi, Gwyn Bevan, Alec Morton, et al.
BMJ (Clinical Research Ed.)|November 12, 2017
Should cost effectiveness analyses for NICE always consider future unrelated medical costs?Pieter van Baal, Alec Morton, Werner Brouwer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Experiences of Structured Elicitation for Model-Based Cost-Effectiveness AnalysesMarta O Soares, Linda Sharples, Alec Morton, et al.
Disability and Rehabilitation. Assistive Technology|November 14, 2024
Mapping gaps and exploring impairment and disability prevalence in South Asian (SAARC) countries: a scoping reviewRaisul Akram, Arjan Buis, Marufa Sultana, et al.
MDM Policy & Practice|January 8, 2020
How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?Alec Morton, Abigail Colson, Axel Leporowski, et al.
Health Economics|February 13, 2019
Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?Itamar Megiddo, Dusan Drabik, Tim Bedford, et al.
BMC Health Services Research|September 24, 2022
Implementation barriers and remedial strategies for community-based health insurance in Bangladesh: insights from national stakeholdersNurnabi Sheikh, Eunice Twumwaa Tagoe, Raisul Akram, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
BMJ Open|May 7, 2026
Economic evaluations of digital health interventions on maternal, newborn and child health in low-income and middle-income countries: a systematic review protocolFei Wu, Brenda Soun, Binqi Zhan, et al.
BMJ Global Health|September 3, 2021
The economics of improving global infectious disease surveillanceLinda de Vries, Marion Koopmans, Alec Morton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 14, 2014
STAR--people-powered prioritization: a 21st-century solution to allocation headachesMara Airoldi, Alec Morton, Jenifer A E Smith, et al.
Health Care Management Science|June 28, 2008
Requisite models for strategic commissioning: the example of type 1 diabetesMara Airoldi, Gwyn Bevan, Alec Morton, et al.
BMJ (Clinical Research Ed.)|November 12, 2017
Should cost effectiveness analyses for NICE always consider future unrelated medical costs?Pieter van Baal, Alec Morton, Werner Brouwer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Experiences of Structured Elicitation for Model-Based Cost-Effectiveness AnalysesMarta O Soares, Linda Sharples, Alec Morton, et al.
Disability and Rehabilitation. Assistive Technology|November 14, 2024
Mapping gaps and exploring impairment and disability prevalence in South Asian (SAARC) countries: a scoping reviewRaisul Akram, Arjan Buis, Marufa Sultana, et al.
MDM Policy & Practice|January 8, 2020
How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?Alec Morton, Abigail Colson, Axel Leporowski, et al.
Health Economics|February 13, 2019
Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?Itamar Megiddo, Dusan Drabik, Tim Bedford, et al.
BMC Health Services Research|September 24, 2022
Implementation barriers and remedial strategies for community-based health insurance in Bangladesh: insights from national stakeholdersNurnabi Sheikh, Eunice Twumwaa Tagoe, Raisul Akram, et al.
Pageof 10